|Mr. Marcelo Rodolfo Hahn||Founder, CEO & Deputy Chairman||無||無||無|
|Claudio Gomes||Chief Financial Officer||無||無||無|
|Mr. Roberto Carlos de Campos Morais||COO & Director||無||無||無|
|Ms. Melissa Angelini||Investor Relations Officer||無||無||無|
|Mr. Roberto Altieri||Legal & Compliance Officer||無||無||無|
Blau FarmacÃªutica S.A., a pharmaceutical company, engages in the production and sale of biological medications in the United States, Colombia, Chile, Peru, Argentina, Uruguay, and Brazil. The company's medications cover various therapeutic classes, such as oncology, hematology, nephrology, rheumatology, infectiology, anesthesiology, intensive care, general practice, and others. Its medications also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolÃticos. The company was founded in 1987 and is headquartered in Cotia, Brazil.
截至 無 止，Blau Farmacêutica S.A. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。